Md. biotech firm nears market with two drugs that could be safer for cancer patients

The CEO said his company aims to make cancer therapies that "eliminate the collateral damage" caused by other drugs on the market.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news